Related Experiment Video
Updated: Jul 8, 2026
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Pediatric Vulvar Lichen Sclerosus: Is a One-Size-Fits-All Prolonged Induction Therapeutic Regimen Effective? A
Boero Veronica1, Caia Carlotta2, Mastrangelo Maria1
1Gynecology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Insights
A prolonged 6-month treatment with potent topical corticosteroids and emollients effectively resolved symptoms in most pediatric vulvar lichen sclerosus (pVLS) cases. This regimen showed high efficacy and a favorable safety profile for pVLS management.
Area of Science:
- Dermatology
- Pediatric Dermatology
- Vulvar Dermatology
Background:
- Pediatric vulvar lichen sclerosus (pVLS) requires effective and safe treatment strategies.
- Prolonged therapeutic courses may be necessary for managing chronic pediatric dermatoses.
Purpose of the Study:
- To assess the efficacy and safety of an extended 6-month induction regimen for pediatric vulvar lichen sclerosus (pVLS).
- The regimen combined ultrapotent topical corticosteroids with daily emollient use.
Main Methods:
- A retrospective observational study involving 94 girls diagnosed with pVLS.
- Standardized treatment: Clobetasol propionate 0.05% ointment with a vitamin E-based emollient over 6 months.
- Clinical and symptom assessments at baseline, 3 months, and 6 months.
Main Results:
- 83% of patients achieved symptom remission, with significant reductions in itching and burning.
- Complete resolution of dysuria, dyschezia, and nocturnal awakenings by 3 months.
- Marked improvement in vulvar signs; modest but significant improvement in perianal signs. No anatomical changes observed. Mild, self-limiting side effects in 8% at 3 months, decreasing to 1% at 6 months. No serious adverse events.
Conclusions:
- A prolonged 6-month induction regimen using ultrapotent topical corticosteroids and emollients is highly effective for pVLS.
- The treatment demonstrates substantial symptom and sign resolution.
- The regimen offers a favorable safety profile for pediatric patients.
Study Objective:
To evaluate the efficacy and safety of a prolonged 6-month induction regimen using ultrapotent topical corticosteroids and daily emollient in the treatment of pediatric vulvar lichen sclerosus (pVLS).
Methods:
This retrospective observational study included 94 girls with clinical diagnosis of pVLS between 2021 and 2025. All patients underwent a standardized treatment protocol with clobetasol propionate 0.05% ointment applied daily for 30 days, every other day for 30 days, and twice weekly for 120 days, alongside daily application of a vitamin E-based emollient. Clinical evaluations and symptom assessments were conducted at baseline (T0), 3 months (T1), and 6 months (T2).
Results:
Symptom remission was achieved in 83% of patients, with marked reductions in itching from 80% (T0) to 13% (T2), *P* < .001, and burning from 36% (T0) to 8% (T2), *P* < .001. Dysuria, dyschezia, and nocturnal awakenings resolved completely by the T1 follow-up. Significant improvements in clinical signs were observed in vulvar area. Improvements in perianal signs were more modest but statistically significant for fissures/erosions (P < .001) and hyperkeratosis/lichenification (P = .018). No significant changes were observed in anatomical alterations. Mild, self-limiting side effects were reported in 8% of patients at T1 and in only 1% at T2. No serious adverse events occurred.
Conclusion:
A prolonged induction regimen with ultrapotent topical corticosteroids demonstrates high efficacy with a substantial symptom and sign resolution and favorable safety profile.
More Related Videos
03:55Urethroplasty with Pedicled Tunica Vaginalis for the Treatment of Long-segment Anterior Urethral Stricture Caused by Lichen Sclerosus of Glans Penis
Published on: October 18, 2024
04:25Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
